Cargando…
Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
Massive efforts on both vaccine development and antiviral research were launched to combat the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We contributed, amongst others, by the development of a high-throughput screening (HTS) antiviral assay against SARS-CoV-2 using a fully au...
Autores principales: | Chiu, Winston, Schepers, Joost, Francken, Thibault, Vangeel, Laura, Abbasi, Kayvan, Jochmans, Dirk, De Jonghe, Steven, Thibaut, Hendrik Jan, Thiel, Volker, Neyts, Johan, Laporte, Manon, Leyssen, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767876/ https://www.ncbi.nlm.nih.gov/pubmed/36565756 http://dx.doi.org/10.1016/j.antiviral.2022.105506 |
Ejemplares similares
-
A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2012) -
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort
por: Zaliani, Andrea, et al.
Publicado: (2022) -
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022) -
A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2011) -
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
por: Do, Thuc Nguyen Dan, et al.
Publicado: (2021)